Sign in
BiophysicsbioRxiv

Site-specific effects of neurosteroids on GABAA receptor activation and desensitization

Y. Sugasawa, W. W. Cheng, J. Bracamontes, Z.-W. Chen, L. Wang, A. L. Germann, S. R. Pierce, T. C. Senneff, K. Krishnan, D. E. Reichert, D. F. Covey, G. Akk, A. Evers

Abstract

This study examines how site-specific binding to the three identified neurosteroid binding sites in the 1{beta}3 GABAA receptor (GABAAR) contributes to neurosteroid allosteric modulation. We found that the potentiating neurosteroid, allopregnanolone, but not its inhibitory 3{beta}-epimer epi-allopregnanolone, binds to the canonical {beta}3(+)-1(-) intersubunit site that mediates receptor activation by neurosteroids. In contrast, both allopregnanolone and epi-allopregnanolone bind to intrasubunit sites in the {beta}3 subunit, promoting receptor desensitization and the 1 subunit promoting ligand-specific effects. Two neurosteroid analogues with diazirine moieties replacing the 3-hydroxyl (KK148 and KK150) bind to all three sites, but do not potentiate GABAAR currents. KK148 is a desensitizing agent, whereas KK150 is devoid of allosteric activity. These compounds provide potential chemical scaffolds for site-specific and general neurosteroid antagonists. Collectively, these data show that differential occupancy and efficacy at three discrete neurosteroid binding sites determine whether a neurosteroid has potentiating, inhibitory, or competitive antagonist activity on GABAARs.

PDFDOI

02 /Specification & Classification

Click any tag to browse matching papers

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.